DDHF20 is an antimicrobial agent against Staphylococcus aureus , targeting and inhibiting its thioredoxin reductase ( TrxR ). It acts as a competitive inhibitor for the NADPH binding site. DDHF20 is expected to be used in research related to antimicrobial infections caused by Staphylococcus aureus.